Lawmaker asks GAO to examine TrumpRx claims of $700 million drug savings
Representative Frank Pallone, the ranking member of the House Energy and Commerce Committee, sent a letter to the Government Accountability Office asking it to assess whether the TrumpRx website has actually saved consumers money. He cited the administration’s claim that the platform has helped Americans save $700 million since its launch in February.
Pallone argued that the White House has not provided key data needed to evaluate the platform’s financial impact, making it difficult to determine if any meaningful benefit has been realized.
TrumpRx does not sell or dispense prescription drugs; instead, it directs users to coupons or discount links for medications.
The lawmaker also pointed to the lack of transparency around most-favored-nation agreements the administration reached with more than two dozen drug manufacturers, which could affect the platform’s pricing outcomes.
This writeup was produced by pharmadog from original reporting by STAT.
Original headline: “STAT+: Lawmaker wants government watchdog to probe TrumpRx over claims about drug savings”
read at STAT ↗
comments(0)
5-min edit window · permanent after that